Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $10 | $12.1K | $8.8K | $5.7K | $4.2K | $3.3K | $3.0K | $4.6K |
| Gross profit | −$10 | −$12.1K | −$8.8K | −$5.7K | −$4.2K | −$3.3K | −$3.0K | −$4.6K |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $772 | $565.5K | $595.8K | $678.8K | $621.1K | $412.4K | $390.7K | $687.5K |
| Operating income | −$1.3M | −$845.0K | −$1.1M | −$1.1M | −$926.0K | −$569.9K | −$650.5K | −$940.9K |
| EBITDA | −$1.3M | −$834.0K | −$1.1M | −$1.1M | −$889.8K | −$566.7K | −$648.2K | −$936.5K |
| Net income | −$886.9K | −$867.0K | −$722.0K | −$745.0K | −$333.0K | −$450.6K | −$1.8M | $759.6K |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -0.08 | -0.08 | -0.06 | -0.05 | -0.02 | -0.02 | -0.06 | 0.02 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds APTCF.
No tracked institution reports a position in APTCF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2019-05-08 | 1-for-10reverse |
No one on the platform has traded APTCF yet.
| +6.02% |
| $146M |
| — |
| MMNFFMedMen Enterprises Inc. | $0.00 | +9900.00% | $138320 | — |
| PPCBPropanc Biopharma, Inc. | $1.52 | -3.80% | $1M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.